DIA
HZNP

Dana Investment Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Dana Investment Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-51,053
Closed -$5.81M – 430
2022
Q4 		$5.81M Sell
51,053
-6,750
-12% -$561K 0.3% 84
2022
Q3 		$3.58M Sell
57,803
-272,188
-82% -$19M 0.2% 98
2022
Q2 		$26.3M Sell
329,991
-8,861
-3% -$839K 1.33% 15
2022
Q1 		$35.7M Buy
338,852
+1,049
+0.3% +$102K 1.64% 7
2021
Q4 		$36.4M Sell
337,803
-18,200
-5% -$1.99M 1.58% 11
2021
Q3 		$39M Sell
356,003
-12,005
-3% -$1.25M 1.77% 7
2021
Q2 		$34.5M Sell
368,008
-20,903
-5% -$1.92M 1.53% 13
2021
Q1 		$35.8M Buy
388,911
+233,921
+151% +$19.7M 1.65% 8
2020
Q4 		$11.3M Buy
154,990
+28,693
+23% +$2.13M 0.56% 62
2020
Q3 		$9.81M Buy
126,297
+82,477
+188% +$5.67M 0.53% 65
2020
Q2 		$2.44M Sell
43,820
-13,861
-24% -$593K 0.13% 104
2020
Q1 		$1.71M Sell
57,681
-11,064
-16% -$374K 0.1% 108
2019
Q4 		$2.49M Sell
68,745
-18,124
-21% -$556K 0.12% 109
2019
Q3 		$2.37M Sell
86,869
-3,722
-4% -$96.2K 0.12% 113
2019
Q2 		$2.18M Sell
90,591
-3,637
-4% -$92.3K 0.11% 130
2019
Q1 		$2.49M Sell
94,228
-8,433
-8% -$200K 0.12% 118
2018
Q4 		$2.01M Sell
102,661
-22,849
-18% -$448K 0.1% 144
2018
Q3 		$2.46M Buy
+125,510
New +$2.39M 0.1% 155

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dana Investment Advisors's HZNP Position: Q1 2023 in Review

Dana Investment Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 51,053 shares — an estimated $5.81M sold.

Dana Investment Advisors first reported a position in HZNP in Q3 2018 and held it in 18 quarters. The position peaked at $39M in Q3 2021. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

  • Dana Investment Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Dana Investment Advisors sold 51,053 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $5.81M.
  • Dana Investment Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2018 and held it in 18 quarters.
  • Dana Investment Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $39M in Q3 2021.
  • 553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Dana Investment Advisors's 13F filing for Q1 2023, filed 15 May 2023.